Items Tagged ‘Dr. Mark Stegall’

June 27, 2017

TOGETHER trial – a personalized approach to detect, treat organ rejection

By Sharon Rosen Sharon Rosen (@sharonhrosen)

For physicians caring for patients after kidney transplantation, it’s a balancing act. They need to select the right immunosuppressant drug and dosage to enable the patient’s immune system to accept the new kidney, but allow it to fight other unwanted infections. Physicians also want to reduce potential side effects from these immunosuppression medications, which can […]

View full entry

Tags: #blood test, #Genomic analysis, #heart transplant, #Immunosuppresion, #kidney transplant, #liver transplant, #Mayo Clinic Transplant Center, #Mayo Clinic Transplant Programs, #organ rejection, #Transplant Genomics Inc., biomarker, center for individualized medicine


June 28, 2016

Mayo Clinic and Transplant Genomics Collaborating to Develop Individualized Treatments to Minimize Transplant Rejection

By Sharon Rosen Sharon Rosen (@sharonhrosen)

A new collaboration is aimed at providing diagnostic tests that can reveal early signs of organ rejection for patients who have undergone an organ transplant. These tests may help physicians adjust immunosuppression medications, which are used to maintain the function of the transplanted organ, prevent organ rejection and minimize side effects. Mayo Clinic Center for […]

View full entry

Tags: center for individualized medicine, Dr. Mark Stegall, Dr. Martin Mai, Dr. Raymond Heilman, Dr. Roy First, genomic medicine, immunosuppression, immunosuppression medications, individualized medicine, organ transplant, organ transplant rejection, pharmacogenomics


Contact Us · Privacy Policy